Sodium Oxybate

In the US, Sodium Oxybate (sodium oxybate systemic) is a member of the drug class miscellaneous anxiolytics, sedatives and hypnotics and is used to treat Cataplexy, Fibromyalgia and Narcolepsy.

US matches:

• Sodium oxybate

Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

N01AX11,N07XX04

CAS registry number (Chemical Abstracts Service)

0000502-85-2

Chemical Formula

C4-H7-Na-O3

Molecular Weight

126

Therapeutic Category

Anesthetic, injectable

Chemical Names

4-Hydroxybuttersäure, Natriumsalz

Butanoic acid, 4-hydroxy-, monosodium salt

Natriioxy butyras

Sodium gammahydroxybutyrate

Foreign Names

• Natrii oxybas (Latin)
• Natrium 4-hydroxybutyrat (German)
• Sodium, oxybate de (French)
• Oxibato de sodio (Spanish)

Generic Names

• Sodium Oxybate (OS: USAN)
• Gam-OH (IS)
• NSC-84223 (IS)
• Wy 3478 (IS: Wyeth)

Brand Names

• Alcover
  CT, Italy; Gerot, Austria



• Gamma-OH
  SERB, France



• Natrija oksibutirats
  Kalceks, Latvia



• Somsanit
  Köhler, Germany



• Xyrem
  Celltech Pharmaceuticals, Luxembourg; Jazz, United States; UCB, Austria; UCB, Germany; UCB, Denmark; UCB, Spain; UCB, Finland; UCB, France; UCB, Ireland; UCB, Netherlands; UCB, Norway; UCB Pharma, United Kingdom; UCB Pharma, Slovenia; UCB-Pharma, Switzerland; Valeant, Canada

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.